Honoring Rakesh K Jain, Ph.D. NFCR funded Scientist
We are so pleased to congratulate National Foundation for Cancer Research funded Scientist Rakesh K. Jain Ph.D. on his tribute event today in Cambridge Massachusetts. A great honor to be feted by his collaborators, peers and fellow scientists and educators at Harvard Medical School and the E.L. Steele Laboratories for…...
National Foundation for Cancer Research and KEW, Inc. announce a collaboration
National Foundation for Cancer Research and KEW, Inc. announce a collaboration to increase awareness of the value of genetic testing. Big Data comes to Cancer Care Choices. #Research4aCure BETHESDA, Maryland (June 8, 2016) – The National Foundation for Cancer Research (NFCR) and Kew, Inc, a private oncology services company based…...
The First Successful Clinical Trial
Clinical Trial and translational medicine. Our CEO and son of the Founder of NFCR likes to talk history. Franklin C. Salisbury, Jr. notes the coincidence, perhaps, that the Salisbury name has long been associated with unheralded basic research that leads to major breakthroughs. Clinical trial and translational medicine – bring…...
Breast Cancer Treatments in the News
New Treatments Could Shrink Breast Cancer in Just 11 Days For patients with HER2-positive breast cancer, a new combination therapy with two drugs could shrink or even eliminate their tumors in just 11 days. About 10% of breast cancers are HER2-positive, which is a subtype of breast cancer that is aggressive…...
Strategic Media Partner
